Parallel Advisors, LLC Castle Biosciences Inc Transaction History

Parallel Advisors, LLC

  • $4.34 Billion
  • Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 27,995 shares of CSTL stock, worth $775,741. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,995
Previous 27,992 0.01%
Holding current value
$775,741
Previous $798,000 6.52%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$26.52 - $34.67 $79 - $104
3 Added 0.01%
27,995 $746,000
Q3 2024

Nov 13, 2024
BUY
$17.4 - $31.47 $26,517 - $47,960
1,524 Added 5.76%
27,992 $798,000
Q2 2024

Aug 08, 2024
SELL
$18.84 - $24.94 $3,768 - $4,988
-200 Reduced 0.75%
26,468 $576,000
Q1 2024

May 06, 2024
SELL
$18.06 - $25.3 $5,418 - $7,590
-300 Reduced 1.11%
26,668 $590,000
Q3 2023

May 20, 2024
SELL
$13.28 - $20.3 $1,155 - $1,766
-87 Reduced 0.32%
26,968 $455,000
Q3 2023

Nov 13, 2023
SELL
$13.28 - $20.3 $1,155 - $1,766
-87 Reduced 0.32%
26,968 $455,000
Q2 2023

May 20, 2024
BUY
$11.66 - $26.0 $58,136 - $129,636
4,986 Added 22.59%
27,055 $371,000
Q2 2023

Aug 04, 2023
BUY
$11.66 - $26.0 $58,136 - $129,636
4,986 Added 22.59%
27,055 $371,000
Q1 2023

May 20, 2024
SELL
$19.47 - $28.49 $89,542 - $131,025
-4,599 Reduced 17.25%
22,069 $501,000
Q4 2022

Feb 03, 2023
SELL
$18.08 - $30.0 $397 - $660
-22 Reduced 0.1%
22,069 $519,000
Q2 2022

Aug 01, 2022
BUY
$16.0 - $45.99 $2,912 - $8,370
182 Added 0.83%
22,091 $485,000
Q1 2022

Apr 28, 2022
BUY
$33.17 - $46.98 $4,643 - $6,577
140 Added 0.64%
21,909 $964,000
Q3 2021

Nov 02, 2021
SELL
$60.13 - $77.6 $1,322 - $1,707
-22 Reduced 0.1%
21,769 $1.45 Million
Q2 2021

Aug 06, 2021
BUY
$50.07 - $76.78 $89,675 - $137,512
1,791 Added 8.96%
21,791 $1.6 Million
Q1 2021

Apr 23, 2021
SELL
$58.92 - $97.33 $294,600 - $486,650
-5,000 Reduced 20.0%
20,000 $1.37 Million
Q4 2020

Feb 02, 2021
SELL
$43.6 - $73.05 $628,712 - $1.05 Million
-14,420 Reduced 36.58%
25,000 $1.68 Million
Q3 2020

Oct 27, 2020
BUY
$38.47 - $52.03 $747,087 - $1.01 Million
19,420 Added 97.1%
39,420 $2.03 Million
Q2 2020

Jul 16, 2020
BUY
$27.28 - $43.01 $545,600 - $860,200
20,000 New
20,000 $753,000

Others Institutions Holding CSTL

# of Institutions
204
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $729M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email